Clinical Trial Update: A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating RO4905417 in patients undergoing coronary artery bypass graft surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Graft Occlusion
• Coronary Artery Disease
• Vascular Disease

Drugs mentioned

• RO4905417

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease, Graft Occlusion, Vascular | Phase 2 | Status: COMPLETED